A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
for Advanced Solid Tumors
7 locations incl. Grand Rapids
Sponsor: Vividion Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06804824·Phase 1·Recruiting·Listed Feb 2025